Treatment of Vein Stenosis or Occlusion With the Oblique Stent

Hangzhou Endonom Medtech Co., Ltd.112 enrolled

Overview

To evaluate the safety and effectiveness of Grency venous stent system in the treatment of iliac vein stenosis or occlusion.

The purpose of this study was to evaluate the safety and effectiveness of a new dedicated venous stent system (Grency) in the treatment of iliac vein stenosis or occlusion. The Grency stent system has a hybrid oblique self-expanding design, which allows precise positioning at the iliocaval confluence.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

112

Conditions

Iliac Vein Stenosis Iliac Vein Occlusion

Interventions

Grency venous stent systemDEVICE

Venous stent implantation during the index procedure

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. subjects aged 18-80 years; 2. CEAP clinical grade C \>=3; 3. iliac vein stenosis \>=50% or occlusion; 4. patients voluntarily sign informed consent and complete follow-up. Exclusion Criteria: 1. subjects in pregnancy or lactation; 2. renal insufficiency; 3. subjects are allergic to contrast agents and anesthetics; 4. subjects are allergic to nitinol; 5. the life expectancy of cancer patients is less than 1 year; 6. the length of the stent is expected to exceed the length of the inguinal ligament; 7. both sides of iliac vein stents were required; 8\. long term bedridden or wheelchair patients; 9. the target vessel of the subject has been implanted into the iliac vein stent; 10. subjects have anticoagulant contraindications or are unable to receive long-term new oral anticoagulant therapy; 11. the investigator judged that the subjects had poor compliance and could not complete the clinical trial; 12. subjects are participating in clinical trials of other drugs or medical devices and have not yet completed the primary end point of the study.

Locations (2)

Chinese People's Liberation Army General Hospital

Beijing, China

Zhongshan Hospital Affiliated to Fudan University

Shanghai, China

Outcomes

Primary Outcomes

Patency rate of venous stent

Freedom from target vessel revascularization ; freedom from in-stent stenosis more than 50% by venography.

Time frame: 12 months post-intervention

Secondary Outcomes

The rate of procedural technical success

Procedure technical success is defined as successful deployment of stent(s) to intended target without stent fracture or migration, as assessed by the investigator during the procedure.

Time frame: During procedure

Change in the clinical symptoms

Change from baseline in the Venous Clinical Severity Score (VCSS) and Clinical-Etiologic-Anatomic-Pathophysiologic (CEAP) Classification at 3 months,6 months, and 12 months. VCSS measures 10 clinical attributes of venous disease (Pain, Varicose Veins,Venous Edema, Skin Pigmentation, Inflammation, Induration, No. Active Ulcers, Active Ulcer Size, Ulcer Duration and Compression Therapy) on a scale of 0 - 3 (Absent 0, Mild 1, Moderate 2, and Severe 3). Clinical-Etiologic-Anatomic-Pathophysiologic (CEAP) Classification is a system that describes a doctor's physical exam findings for vein problem(s), the cause of the problem(s), the location in the leg, and the mechanism responsible for the manifestation of the vein problem. For Clinicalclassification, the clinical components indicates disease severity, ranging from none (0 points) to active ulcers (6 points).

Time frame: Baseline, 3 months,6 months, and12 months post-intervention

The rate of device related major adverse events(MAE)

Time frame: 3,6,12 months post-intervention

The rate of adverse events (AE)

Time frame: 3,6,12 months post-intervention

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.